Researchers test new tool to gauge patient Well-Being during tumor treatment
NCT ID NCT04106531
Summary
This study aimed to test a new 10-question survey designed to measure quality of life in people taking medication for a benign pituitary tumor called a prolactinoma. Eight adult patients who were starting new medication filled out the survey at the beginning of treatment and over 13 weeks. The goal was to see if the survey was reliable and consistent for tracking how patients feel during their therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLACTINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.